Literature DB >> 2762227

Controlled gastric emptying. II. In vitro erosion and gastric residence times of an erodible device in beagle dogs.

R Cargill1, K Engle, C R Gardner, P Porter, R V Sparer, J A Fix.   

Abstract

An erodible gastric retention device fabricated from various polymeric blends was examined in vitro for its dissolution properties and in vivo in fasting dogs for assessment of its gastric retention potential. Dissolution studies were conducted with extruded rods of polymer blends to assess their potential as candidates for the erodible component of a gastrically retained device. Based on results from dissolution studies, rods of poly(ortho ester)/polyethylene blends (POE/PE) (45% erosion at pH 1.5 and 24 hr) were used to fabricate arms for tetrahedron-shaped devices. Corners for the tetrahedral device were fabricated from Silastic 382 loaded with 15% barium sulfate for X-ray visualization. Beagle dogs were dosed with tetrahedron-shaped test devices administered in gelatin capsules and gastric retention monitored by X ray over a 24-hr period. A comparison of in vitro erosion rates and in vivo performance of various polymer blends indicated a definite trend for increased gastric retention of devices made from the more slowly eroding blends. The results indicate that the blending of erodible and nonerodible polymers is a valid approach for obtaining materials that will provide the necessary structural properties to achieve gastric retention yet lose integrity within a desired time.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762227     DOI: 10.1023/a:1015976709043

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  1 in total

Review 1.  Controlled release of biologically active compounds from bioerodible polymers.

Authors:  J Heller
Journal:  Biomaterials       Date:  1980-01       Impact factor: 12.479

  1 in total
  5 in total

Review 1.  Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form.

Authors:  David H Altreuter; Ameya R Kirtane; Tyler Grant; Cecilia Kruger; Giovanni Traverso; Andrew M Bellinger
Journal:  Expert Opin Drug Deliv       Date:  2018-11-13       Impact factor: 6.648

2.  A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment.

Authors:  Matthew D Burke; J Scott Staton; Ann W Vickers; Erin E Peters; Mark D Coffin
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.

Authors:  Andrew M Bellinger; Mousa Jafari; Tyler M Grant; Shiyi Zhang; Hannah C Slater; Edward A Wenger; Stacy Mo; Young-Ah Lucy Lee; Hormoz Mazdiyasni; Lawrence Kogan; Ross Barman; Cody Cleveland; Lucas Booth; Taylor Bensel; Daniel Minahan; Haley M Hurowitz; Tammy Tai; Johanna Daily; Boris Nikolic; Lowell Wood; Philip A Eckhoff; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2016-11-16       Impact factor: 17.956

4.  Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.

Authors:  Ameya R Kirtane; Omar Abouzid; Daniel Minahan; Taylor Bensel; Alison L Hill; Christian Selinger; Anna Bershteyn; Morgan Craig; Shirley S Mo; Hormoz Mazdiyasni; Cody Cleveland; Jaimie Rogner; Young-Ah Lucy Lee; Lucas Booth; Farhad Javid; Sarah J Wu; Tyler Grant; Andrew M Bellinger; Boris Nikolic; Alison Hayward; Lowell Wood; Philip A Eckhoff; Martin A Nowak; Robert Langer; Giovanni Traverso
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

5.  Ingestible hydrogel device.

Authors:  Xinyue Liu; Christoph Steiger; Shaoting Lin; German Alberto Parada; Ji Liu; Hon Fai Chan; Hyunwoo Yuk; Nhi V Phan; Joy Collins; Siddartha Tamang; Giovanni Traverso; Xuanhe Zhao
Journal:  Nat Commun       Date:  2019-01-30       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.